信利國際(00732.HK)擬189.72萬元增持信利光電近0.4%股權
格隆匯8月13日丨信利國際(00732.HK)宣佈,於2021年8月13日,公司間接全資附屬公司信利工業(作為買方)訂立協議五、協議六及協議七,以收購公司的間接非全資附屬公司信利光電分別約0.0879%、0.1755%及0.1074%股權。協議五、協議六及協議七並非互為條件,收購代價分別為人民幣449,291.64元、人民幣898,583.28元及人民幣549,343.98元。
據悉,信利光電為於中國註冊成立之公司,併為公司的間接非全資附屬公司,其主要業務為製造觸控產品、微型相機模組及指紋識別模組。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.